Ledger.Open graph →
SEC Form D · filed April 21, 2020

FATE THERAPEUTICS INC

Offering
$50.0M
Sold
$50.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Cindy D. Tahl · San Diego, CAExecAmir S. Nashat · San Diego, CADirectorTimothy P. Coughlin · San Diego, CADirectorJohn S. Mendlein · San Diego, CADirectorRobert S. Epstein · San Diego, CADirectorWilliam S. Rastetter · San Diego, CADirectorKarin Jooss · San Diego, CADirectorMichael Lee · San Diego, CADirectorShefali Agarwal · San Diego, CADirectorJ. Scott Wolchko · San Diego, CAExec · DirectorJesper P. Anderson · Freemont, CADirectorHarley L. Stowell, Iii · Canton, MADirectorMatthew W. Collins · Canton, MADirectorKarin Jooss · San Diego, CADirectorRick Hennessey · Pompano Beach, FLDirectorNisa B. Leung · Kowloon, Hong KongDirectorPeter P. Siwinski · San Francisco, CADirectorDavid Burns · GARDENA, CAExec · DirectorKimmie Serrano · Payette, IDDirectorMatthew Petros · GARDENA, CAExecKen Hood · GARDENA, CADirectorMichael Feinstein · Chciago, ILDirectorPaul A. Froning · Chicago, ILDirectorScott R. Macgregor · Chicago, ILDirectorFocus Healthcare Partners LLC · Chicago, ILDirectorCurt P. Schaller · Chicago, ILExec · DirectorFocus SH I GP LLC · Chicago, ILExecCary Davis · McLean, VADirectorLauren Zlentz · McLean, VADirectorHila Karah · Herzliya, L3Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗